Diabetes decisions — 2025

The Board remands the appeal for additional development, including obtaining relevant treatment records and scheduling a new examination to clarify certain testing results and distinguish between symptoms of varicose veins and diabetic PVD.

The Board denied a separate compensable rating for bilateral diabetic retinopathy and remanded the claims for service connection for skin condition, chloracne, acne, soft tissue sarcoma (basal cell carcinoma) due to herbicide exposure.

The Board granted service connection for diabetes mellitus type II, based on the Veteran's presumed exposure to herbicide agents during his service in or near the Korean Demilitarized Zone.

The Board granted readjudication of service connection for bilateral sensorineural hearing loss, diabetes mellitus type II, and obstructive sleep apnea based on new evidence.

The Board remands the claim for service connection for diabetes mellitus type II due to an inadequate VA medical opinion.

The Board has granted readjudication of the claims for service connection for a bilateral eye disorder, hypertension, diabetes, stroke, neurological disorder, right side body weakness, memory disorder, and balance disorder based on new and relevant evidence being received.

The Board remands the claim for service connection of diabetes mellitus, type 2 to obtain an adequate VA opinion regarding its etiology.

The Board remands the claims for service connection for diabetes mellitus type II and related conditions due to a lack of adequate medical evidence.

The Board denied service connection for erectile dysfunction as secondary to hypertension, finding no current diagnosis. The claims for diabetes mellitus and leg cramps were remanded for further development.

The Board remands the claim for service connection for diabetes mellitus type II, to include as secondary to service connected PTSD, for an addendum opinion.

The Board remands the claims for service connection for ischemic heart disease, cardiomyopathy, a prostate disorder, diabetes mellitus, and hypertension to obtain additional evidence regarding toxic exposure risk activities during the Veteran's service.

The Board granted a 40 percent rating for Type II diabetes mellitus, and remanded the issue of entitlement to a TDIU prior to December 12, 2023.

The Board denied service connection for diabetes mellitus, type II, a skin disorder, and a heart disorder as the evidence did not support a finding that these conditions were related to the Veteran's active military service.

The Board denied service connection for diabetes mellitus, erectile dysfunction, and hypogonadism as the evidence did not support a finding that these conditions were incurred in or related to active duty service.

The Board remands the matter of entitlement to TDIU for an additional Supplemental Statement of the Case due to new evidence and VA treatment records being associated with the file after the July 2024 SSOC.

The Board denied service connection for coronary artery disease, hypertension, a seizure disability, peripheral vascular disease, chronic kidney disease, and diabetes mellitus as the record does not show that these conditions were incurred in or caused by service.

The Board denied service connection for diabetes, finding that there is no medical evidence linking the Veteran's diabetes to his service-connected PTSD.

The Board denied service connection for diabetes mellitus, type II, hypertension, bilateral hearing loss, and a heart murmur as the evidence did not show that these conditions were related to the Veteran's active duty service.

The Board denied an initial compensable rating for bilateral hearing loss and remanded the claims for service connection for diabetes mellitus Type II, hypertension, and coronary artery disease.

The Board remands all claims for service connection due to a duty to assist error and the need to verify toxic exposure at Fort McClellan.